 |
|
Temporal Trends of Incident Human Immunodeficiency Virus Infection in a Cohort of Injecting Drug Users in Baltimore, Md
Kenrad E. Nelson, MD;
David Vlahov, PhD;
Liza Solomon, DrPH;
Sylvia Cohn, MPH;
Alvaro Muñoz, PhD
Arch Intern Med. 1995;155(12):1305-1311.
Abstract
| |
Objective
To measure the temporal trends in the incidence of infection with human immunodeficiency virus in a cohort of injecting drug users in Baltimore, Md, between 1988 and 1992.
Design
Study subjects were screened for antibodies to human immunodeficiency virus by enzyme-linked immunosorbent assay and confirmed with Western blot. They were followed up at 6-month intervals with repeated serologic screening and comprehensive interviews for human immunodeficiency virus risk factors.
Setting
Special study clinic.
Participants
A cohort of 2960 participants were recruited and screened between February 1988 and March 1989. Recruitment criteria included an age of 18 years or older, a history of illicit drug injection since 1978, and the absence of the acquired immunodeficiency syndrome; subjects were subsequently tested for human immunodeficiency virus antibodies. Most subjects (85%) were not receiving methadone treatment at baseline and were recruited by word of mouth.
Main Outcome Measure
Human immunodeficiency virus seroconversion.
Results
Of the 2247 seronegative participants at baseline, 1532 were followed up, and 188 (12.3%) had seroconverted by December 1992. The incidence of human immunodeficiency virus infection over time among users declined somewhat, especially among women; the overall incidence was 1.90 per 100 person-semesters, or 3.80% annually. The incidence, adjusted for gender, was higher in younger (<35 years) than older ( 35 years) subjects (relative incidence, 1.75; 95% confidence interval, 1.29 to 2.38) and in women compared with men, adjusted for age (relative incidence, 1.29; 95% confidence interval, 0.95 to 1.80). The relative incidence among active compared with inactive drug users adjusted for age and gender was 1.58 (95% confidence interval, 1.06 to 2.35).
Conclusions
Although the incidence of human immunodeficiency virus infection in this cohort of injecting drug users in Baltimore declined somewhat during the 4 years of follow-up, especially among women, the persistent annual incidence of nearly 4% during 3 to 4 years of observation suggests the need for additional strategies for prevention of infection, especially among those who continue injecting drugs. Newer methods of prevention, such as provision of sterile injection equipment, an effective human immunodeficiency virus vaccine, and wider availability of effective treatment or prevention of drug addiction, are urgently needed in these high-risk populations.
(Arch Intern Med. 1995;155:1305-1311)
Author Affiliations
From the Department of Epidemiology, School of Hygiene and Public Health, The Johns Hopkins University, Baltimore, Md.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Effects of Race, Neighborhood, and Social Network on Age at Initiation of Injection Drug Use
Fuller et al.
AJPH 2005;95:689-695.
ABSTRACT
| FULL TEXT
Trends in Human Immunodeficiency Virus Seroincidence among Street-Recruited Injection Drug Users in San Francisco, 1987-1998
Kral et al.
Am J Epidemiol 2003;157:915-922.
ABSTRACT
| FULL TEXT
Sociodemographic and Behavioral Characteristics Associated with Timeliness and Retention in a 6-Month Follow-up Study of High-Risk Injection Drug Users
Messiah et al.
Am J Epidemiol 2003;157:930-939.
ABSTRACT
| FULL TEXT
Temporal Trends in the Incidence of Human Immunodeficiency Virus Infection and Risk Behavior among Injection Drug Users in Baltimore, Maryland, 1988-1998
Nelson et al.
Am J Epidemiol 2002;156:641-653.
ABSTRACT
| FULL TEXT
Risk factors for elevated HIV incidence rates among female injection drug users in Vancouver
Spittal et al.
CMAJ 2002;166:894-899.
ABSTRACT
| FULL TEXT
Sex Differences in Risk Factors for HIV Seroconversion Among Injection Drug Users: A 10-Year Perspective
Strathdee et al.
Arch Intern Med 2001;161:1281-1288.
ABSTRACT
| FULL TEXT
Human Immunodeficiency Virus Seroconversion and Evolution of the Hepatitis C Virus Quasispecies
Mao et al.
J. Virol. 2001;75:3259-3267.
ABSTRACT
| FULL TEXT
Snapshot Estimators of Recent HIV Incidence Rates
Kaplan and Brookmeyer
Operations Research 1999;47:29-37.
ABSTRACT
Psychiatric and Substance Use Comorbidity Among Treatment-Seeking Opioid Abusers
Brooner et al.
Arch Gen Psychiatry 1997;54:71-80.
ABSTRACT
|
